HYALGAN® Efficacy Data

Largest US study shows proven pain relief

HYALGAN® demonstrated significant pain relief with a 5-injection regimen vs placebo in the largest pivotal controlled hyaluronate study conducted in the US (N=495) among patients with OA of the knee.8

HYALGAN®has demonstrated 3 injection efficacy in 3 placebo controlled clinical trials.

*Some patients may experience benefit with 3 HYALGAN® injections given at weekly intervals. This has been noted in studies of patients receiving 3 injections who were followed for 60 days.10

HYALGAN® is the only hyaluronan proven safe and effective for repeat use in a 30-month study25

Important Safety Information for HYALGAN®

  • HYALGAN® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpha-rmacologic therapy, and to simple analgesics, eg, acetaminophen
  • HYALGAN® is contraindicated in patients with known hypersensitivity to hyaluronate preparations. Intra-articular injections are contraindicated in cases of past and present infections or skin diseases in the area of the injection site
  • The effectiveness of a single treatment cycle of less than 3 injections has not been established
  • In the US clinical trial of 495 patients, the only adverse event showing statistical significance vs placebo was injection-site pain
  • Other adverse events included gastrointestinal complaints, headache, local ecchymosis and rash, local joint pain and swelling, and local pruritus. However, the incidence of these events was similar in the HYALGAN®-treated and placebo groups
  • In other clinical studies, the frequency and severity of adverse events occurring during repeat treatment cycles did not increase over that reported for a single treatment cycle

Click here for additional important information for HYALGAN®.